BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35747687)

  • 1. MAIP1-Related Tumor Immune Infiltration: As a Potential Prognostic Biomarker for Esophageal Cancer.
    He X; Gan F; Lin Y; Liu G; Lin Y; Chen D
    J Immunol Res; 2022; 2022():7282842. PubMed ID: 35747687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer.
    Xie Y; Fu R; Xiao Z; Li G
    Pathol Oncol Res; 2022; 28():1610030. PubMed ID: 35356506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
    Tang S; Zhuge Y
    Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer.
    Yang L; Zhao Q; Wang X; Pilapong C; Li Y; Zou J; Jin J; Rong J
    Cancer Med; 2023 Feb; 12(4):4993-5008. PubMed ID: 36226375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value and Immune-Infiltration Pattern of
    Yang Z; Shen X; Luo S; Li Y
    Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
    Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
    Front Genet; 2021; 12():696912. PubMed ID: 34512722
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of gene expression profiles of esophageal cancer patients with different nonsynonymous tumor mutation burden.
    Li J; Chen H; Guo H; Qiu M; Yang F
    Thorac Cancer; 2020 Aug; 11(8):2270-2278. PubMed ID: 32558329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.
    Xu X; Wang D; Li N; Sheng J; Xie M; Zhou Z; Cheng G; Fan Y
    Ann Surg Oncol; 2022 May; 29(5):2930-2940. PubMed ID: 34751872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
    Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
    Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
    BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.